Literature DB >> 18496370

Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation.

Raghavan Murugan1, Ramesh Venkataraman, Abdus S Wahed, Michele Elder, Georgene Hergenroeder, Melinda Carter, Nicholas J Madden, David Powner, John A Kellum.   

Abstract

OBJECTIVES: Brain death induces a massive inflammatory response. However, the influence of this inflammatory response on organ procurement, transplantation, and recipient outcome is unknown. We describe the inflammatory response characteristics in brain-dead organ donors and examine associations with organ transplantation and recipient survival. We test the hypothesis that increased inflammatory response is associated with fewer organs transplanted and decreased recipient survival.
DESIGN: Prospective, observational, cohort study.
SETTING: Two large intensive care units of tertiary care university hospitals in the United States. PATIENTS: We recruited 30 consecutive brain-dead organ donors and 78 recipients between April 11, 2004, and November 23, 2004; recipients were followed through May 2005. Following declaration of brain death, we collected data on donor demographics, mechanism of brain death, number of organs procured and transplanted, and recipient characteristics. Plasma cytokines (tumor necrosis factor, interleukin-6, interleukin-10) were measured in donors at baseline following study enrollment, every hour for the first 4 hrs, and immediately before organ procurement for transplantation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We examined the relationships among clinical characteristics, demographics, and cytokine response in donors and their influence on organ procurement and transplantation using multivariable regression and recipient's 6-month hospital-free survival using a Cox proportional hazards regression. One hundred-eighteen organs were procured from 30 donors, and 91 (77%) were transplanted (mean of three organs transplanted per donor). All cytokines were increased following brain death. Older age in donors was significantly associated with lower number of organs transplanted (p < .001). Higher plasma interleukin-6 concentrations in donors before organ procurement was significantly associated with lower 6-month hospital-free survival in recipients (hazard ratio 1.77; 95% confidence interval, 1.17-2.69, p < .007).
CONCLUSIONS: Among brain-dead organ donors, older age donors contribute fewer organs for transplantation, and increased donor interleukin-6 level before organ procurement is associated with lower recipient six-month hospital-free survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18496370     DOI: 10.1097/CCM.0b013e318174d89f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

Review 1.  What's new in organ donation: better care of the dead for the living.

Authors:  Ali Al-Khafaji; Raghavan Murugan; John A Kellum
Journal:  Intensive Care Med       Date:  2013-08-03       Impact factor: 17.440

2.  Donor Pretreatment With IL-1 Receptor Antagonist Attenuates Inflammation and Improves Functional Potency in Islets From Brain-Dead Nonhuman Primates.

Authors:  Juan S Danobeitia; Matthew S Hanson; Peter Chlebeck; Elisa Park; Jamie M Sperger; Alice Schwarznau; Luis A Fernandez
Journal:  Cell Transplant       Date:  2014-04-22       Impact factor: 4.064

3.  Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction.

Authors:  Justin Pollara; R Whitney Edwards; Liwen Lin; Victoria A Bendersky; Todd V Brennan
Journal:  JCI Insight       Date:  2018-08-09

4.  Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial.

Authors:  Ali Al-Khafaji; Michele Elder; Daniel J Lebovitz; Raghavan Murugan; Michael Souter; Susan Stuart; Abdus S Wahed; Ben Keebler; Dorrie Dils; Stephanie Mitchell; Kurt Shutterly; Dawn Wilkerson; Rupert Pearse; John A Kellum
Journal:  Intensive Care Med       Date:  2015-01-13       Impact factor: 17.440

5.  Randomized trial to evaluate nutritional status and absorption of enteral feeding after brain death.

Authors:  Georgene W Hergenroeder; Norman H Ward; Xiaoying Yu; Antone Opekun; Anthony N Moore; Claudia A Kozinetz; David J Powner
Journal:  Prog Transplant       Date:  2013-12       Impact factor: 1.187

Review 6.  Management of donation after brain death (DBD) in the ICU: the potential donor is identified, what's next?

Authors:  Ignacio Martin-Loeches; Alberto Sandiumenge; Julien Charpentier; John A Kellum; Alan M Gaffney; Francesco Procaccio; Glauco A Westphal
Journal:  Intensive Care Med       Date:  2019-02-28       Impact factor: 17.440

7.  Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation.

Authors:  Shengnan Li; Shu Wang; Raghavan Murugan; Ali Al-Khafaji; Daniel J Lebovitz; Michael Souter; Susan R N Stuart; John A Kellum
Journal:  J Crit Care       Date:  2018-08-18       Impact factor: 3.425

8.  Preload responsiveness is associated with increased interleukin-6 and lower organ yield from brain-dead donors.

Authors:  Raghavan Murugan; Ramesh Venkataraman; Abdus S Wahed; Michele Elder; Melinda Carter; Nicholas J Madden; John A Kellum
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

9.  Monitoring Organ Donors to Improve Transplantation Results (MOnIToR) trial methodology.

Authors:  Ali Al-Khafaji; Raghavan Murugan; Abdus S Wahed; Daniel J Lebovitz; Michael J Souter; John A Kellum
Journal:  Crit Care Resusc       Date:  2013-09       Impact factor: 2.159

Review 10.  Brain death and management of the potential donor.

Authors:  Marcia Harumy Yoshikawa; Nícollas Nunes Rabelo; Leonardo Christiaan Welling; João Paulo Mota Telles; Eberval Gadelha Figueiredo
Journal:  Neurol Sci       Date:  2021-06-17       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.